Divi's Laboratories Ltd
Company Profile
Business description
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients, with a predominance in exports. It also, through its custom synthesis, supports pharma companies for their patented products business from gram-scale requirements for clinical trials to launch, as well as late-life cycle management. Geographically, the company derives maximum revenue from Europe, and the rest from America, India, Asia (excluding India), and the Rest of the world.
Contact
Cyber Hills
Divi Towers, 1-72/23(P)/DIVIS/303
Gachibowli
HyderabadTG500032
INDT: +91 4066966300
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
9,109
Stocks News & Analysis
stocks
Anglo American strikes deal to create a new copper giant
stocks
The ‘other’ AI chip behemoth that might just be getting started
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,071.40 | 9.10 | -0.10% |
| CAC 40 | 7,823.52 | 62.20 | 0.80% |
| DAX 40 | 23,703.65 | 70.70 | 0.30% |
| Dow JONES (US) | 46,115.88 | 624.96 | 1.37% |
| FTSE 100 | 9,297.58 | 72.19 | 0.78% |
| HKSE | 26,086.32 | 113.94 | -0.43% |
| NASDAQ | 22,040.97 | 154.91 | 0.71% |
| Nikkei 225 | 44,372.50 | 534.83 | 1.22% |
| NZX 50 Index | 13,229.15 | 47.09 | -0.35% |
| S&P 500 | 6,584.86 | 52.82 | 0.81% |
| S&P/ASX 200 | 8,805.00 | 8.80 | -0.10% |
| SSE Composite Index | 3,875.31 | 63.09 | 1.65% |